These technologies are highly versatile. Key formulation challenges that can be addressed using liquid and semi-solid fill technologies, in either liquid fill hard capsules or soft gel finished dosage forms, include bioavailability enhancement, high potency/low dose and API stability. These technologies provide straightforward and efficient encapsulation of difficult-to-formulate actives such as: low-melting point compounds, hot melts, high viscosity fills, solid dispersions, low-dose actives and highly potent actives. Specialized applications include coated liquid fill hard capsules for optimal drug delivery to the colon, and capsule-in-capsule technology for combination drugs or dual drug release profiles.
Please note that Lonza has updated its Privacy Policy. By visiting our website or using services provided by Lonza, you are accepting the practices described in the Privacy Policy.
We also use cookies on our websites. Cookies allow us to give you the best browsing experience and help us to understand how you use our site. You can disable cookies but parts of our website may not work. Please read our updated Cookies Policy for information about which cookies we use and the information we collect. By continuing to use this website, you agree that we may store and access cookies on your device.
By clicking "I Agree", you confirm that you are above the age of 16, that you have read and understood the Privacy Policy and the Cookies Policy, and that you agree to the collection, use and processing of your Personal Information by Lonza in accordance with said policies.